
GLP-1 without a Prescription; Bariatric Patient; When They Don't Go as Expected (2025)
Learning Objectives:
- To be familiar with the impact of GLP and GLP/GIP therapy for reducing weight.
- To be familiar with the process of compounding medication.
- To be familiar with the potential deleterious effects of compounding medications.
Jeffrey S. Freeman, DO, FACOI
Professor of Internal Medicine & Chairman of Division Endocrinology and Metabolism
Philadelphia College of Osteopathic Medicine
Professor of Internal Medicine and Chairman of Division Endocrinology and Metabolism
Philadelphia College of Osteopathic Medicine
Dr. Freeman has disclosed the following relevant financial relationships: Novo Nordisk - Honoraria Speaker Bayer- Honoraria Speaker
Key:





Webcast
04/22/2025 at 8:55 AM (EDT) | Recorded On: 04/22/2025 | 43 minutes
04/22/2025 at 8:55 AM (EDT) | Recorded On: 04/22/2025 | 43 minutes